keyword
MENU ▼
Read by QxMD icon Read
search

Diabetes costs utilization

keyword
https://www.readbyqxmd.com/read/29449950/impact-of-malnutrition-on-survival-and-healthcare-utilization-in-medicare-beneficiaries-with-diabetes-a-retrospective-cohort-analysis
#1
Naseer Ahmed, Yong Choe, Vikkie A Mustad, Sumita Chakraborty, Scott Goates, Menghua Luo, Jeffrey I Mechanick
Objective: The aim of this study was to examine the impact of pre-existing malnutrition on survival and economic implications in elderly patients with diabetes. Research design and methods: A retrospective observational study was conducted to examine the impact of malnutrition with or without other significant health conditions on survival time and healthcare costs using the Centers for Medicare and Medicaid Services (CMS) data from 1999 to 2014 for beneficiaries with a confirmed first date of initial diagnosis of diabetes (n=15 121 131)...
2018: BMJ Open Diabetes Research & Care
https://www.readbyqxmd.com/read/29445964/different-methods-for-modelling-severe-hypoglycaemic-events-implications-for-effectiveness-costs-and-health-utilities
#2
Edna Keeney, Dalia Dawoud, Sofia Dias
BACKGROUND: Clinical trials report severe hypoglycaemic events as the number of patients with at least one event out of the total randomised or number of events for a given total exposure. Different network meta-analysis models have been used to analyse these different data types. OBJECTIVE: This aim of this article was to establish the impact of using the different models on effectiveness, costs and health utility estimates. METHODS: We analysed a dataset used in a recent network meta-analysis of severe hypoglycaemic events conducted to inform National Institute for Health and Care Excellence recommendations regarding basal insulin choice for patients with type 1 diabetes mellitus...
February 14, 2018: PharmacoEconomics
https://www.readbyqxmd.com/read/29441119/diagnosis-monitoring-and-prevention-of-exposure-related-non-communicable-diseases-in-the-living-and-working-environment-dimopex-project-is-designed-to-determine-the-impacts-of-environmental-exposure-on-human-health
#3
REVIEW
Lygia Therese Budnik, Balazs Adam, Maria Albin, Barbara Banelli, Xaver Baur, Fiorella Belpoggi, Claudia Bolognesi, Karin Broberg, Per Gustavsson, Thomas Göen, Axel Fischer, Dorota Jarosinska, Fabiana Manservisi, Richard O'Kennedy, Johan Øvrevik, Elizabet Paunovic, Beate Ritz, Paul T J Scheepers, Vivi Schlünssen, Heidi Schwarzenbach, Per E Schwarze, Orla Sheils, Torben Sigsgaard, Karel Van Damme, Ludwine Casteleyn
The WHO has ranked environmental hazardous exposures in the living and working environment among the top risk factors for chronic disease mortality. Worldwide, about 40 million people die each year from noncommunicable diseases (NCDs) including cancer, diabetes, and chronic cardiovascular, neurological and lung diseases. The exposure to ambient pollution in the living and working environment is exacerbated by individual susceptibilities and lifestyle-driven factors to produce complex and complicated NCD etiologies...
2018: Journal of Occupational Medicine and Toxicology
https://www.readbyqxmd.com/read/29436251/improvement-of-metabolic-control-and-diabetes-management-in-insulin-treated-patients-results-in-substantial-cost-savings-for-the-german-health-system
#4
Katharina Fritzen, Bettina Gutschek, Benedikte Coucke, Katerina Zakrzewska, Michael Hummel, Oliver Schnell
BACKGROUND: Self-monitoring of blood glucose (SMBG) using the ColourSure™ Technology to visualize target range showed improvement of metabolic control and overall diabetes self-management in insulin-treated patients. This economic analysis aimed to identify cost savings for the German health system resulting from an HbA1c reduction due to the utilization of user-friendly glucose meters. METHODS: Patient data from a recently published observational study on SMBG were used for risk evaluations using the UKPDS risk engine...
February 1, 2018: Journal of Diabetes Science and Technology
https://www.readbyqxmd.com/read/29431201/the-in-hospital-burden-of-hidradenitis-suppurativa-in-patients-with-inflammatory-bowel-disease-a-decade-nationwide-analysis-from-2004-to-2014
#5
Alvaro J Ramos-Rodriguez, Dmitriy Timerman, Ali Khan, Lauren Bonomo, Manrup K Hunjan, Alejandro Lemor
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that significantly affects the patient's quality of life. Multiple studies have shown a strong association between HS and inflammatory bowel disease (IBD). Our primary goal was to explore the in-hospital burden of HS on patients with IBD. Our secondary goal was to establish unique baseline characteristics and comorbidities of IBD patients with HS. METHODS: This was a retrospective cohort study using the National Inpatient Sample (NIS) database for the years 2004 through 2014...
February 12, 2018: International Journal of Dermatology
https://www.readbyqxmd.com/read/29430799/direct-medical-costs-of-diabetes-mellitus-in-the-year-of-mortality-and-year-before-mortality
#6
Carlos King Ho Wong, Fangfang Jiao, Eric Ho Man Tang, Thaison Tong, Praveen Thokala, Cindy Lo Kuen Lam
AIMS: Studies have shown that health service utilization often increases in few years immediately before death. Estimates of direct medical cost of diabetes mellitus (DM) in mortality year and the previous year is not well understood. This study aimed to report the health resource use and estimate the direct medical costs among DM patients in the year of mortality and the year before mortality. MATERIALS AND METHODS: We analysed a population-based, retrospective cohort study including all adults with DM diagnosis in Hong Kong between 2009 and 2013, and death between January 1, 2010 and December 31, 2013...
February 12, 2018: Diabetes, Obesity & Metabolism
https://www.readbyqxmd.com/read/29391064/cost-effectiveness-analysis-of-metformin-dipeptidyl-peptidase-4-inhibitors-compared-to-metformin-sulfonylureas-for-treatment-of-type-2-diabetes
#7
Christina S Kwon, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio
BACKGROUND: Patients with type 2 diabetes (T2D) typically use several drug treatments during their lifetime. There is a debate about the best second-line therapy after metformin monotherapy failure due to the increasing number of available antidiabetic drugs and the lack of comparative clinical trials of secondary treatment regimens. While prior research compared the cost-effectiveness of two alternative drugs, the literature assessing T2D treatment pathways is scarce. The purpose of this study was to evaluate the long-term cost-effectiveness of dipeptidyl peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) as second-line therapy in combination with metformin in patients with T2D...
February 1, 2018: BMC Health Services Research
https://www.readbyqxmd.com/read/29382633/prediction-of-incident-hypertension-within-the-next-year-prospective-study-using-statewide-electronic-health-records-and-machine-learning
#8
Chengyin Ye, Tianyun Fu, Shiying Hao, Yan Zhang, Oliver Wang, Bo Jin, Minjie Xia, Modi Liu, Xin Zhou, Qian Wu, Yanting Guo, Chunqing Zhu, Yu-Ming Li, Devore S Culver, Shaun T Alfreds, Frank Stearns, Karl G Sylvester, Eric Widen, Doff McElhinney, Xuefeng Ling
BACKGROUND: As a high-prevalence health condition, hypertension is clinically costly, difficult to manage, and often leads to severe and life-threatening diseases such as cardiovascular disease (CVD) and stroke. OBJECTIVE: The aim of this study was to develop and validate prospectively a risk prediction model of incident essential hypertension within the following year. METHODS: Data from individual patient electronic health records (EHRs) were extracted from the Maine Health Information Exchange network...
January 30, 2018: Journal of Medical Internet Research
https://www.readbyqxmd.com/read/29378486/incremental-burden-of-type-2-diabetes-in-patients-experiencing-cardiovascular-hospitalizations
#9
Anna D Coutinho, Aditya D Raju, Weijia Wang, Dana Stafkey-Mailey, Sharash Shett, Stephen D Sander
OBJECTIVE: To evaluate the incremental economic burden of type 2 diabetes in patients experiencing cardiovascular (CV) hospitalizations. RESEARCH DESIGN AND METHODS: Adults with ≥1 CV hospitalization were identified using a US-based healthcare claims database from 07/01/2011-06/30/2014. Outcomes for patients surviving the index hospitalization were compared between patients with vs without type 2 diabetes (cohorts were identified in the pre-index period). Subsequent CV hospitalizations were evaluated using Cox proportional hazards models...
January 29, 2018: Current Medical Research and Opinion
https://www.readbyqxmd.com/read/29375180/designing-a-food-tax-to-impact-food-related-non-communicable-diseases-the-case-of-chile
#10
Juan Carlos Caro, Lindsey Smith-Taillie, Shu Wen Ng, Barry Popkin
The global shift towards diets high in sugar-sweetened beverages (SSBs) and energy dense ultra-processed foods is linked to higher prevalence of obesity, diabetes and most other noncommunicable diseases (NCDs), causing significant health costs. Chile has the highest SSB consumption in the world, very high junk food intake and very rapid increases in these poor components of the diet plus obesity prevalence. This study's purpose is to compare the effect of different tax schemes for SSBs and ultra-processed foods on nutrient availability, utilizing price-elasticities, which are estimated from a Quadratic Almost Ideal Demand System model, using the 2011-2012 Income and Expenditure survey...
August 2017: Food Policy
https://www.readbyqxmd.com/read/29370080/controversies-and-advances-in-gestational-diabetes-an-update-in-the-era-of-continuous-glucose-monitoring
#11
REVIEW
Marina P Carreiro, Anelise I Nogueira, Antonio Ribeiro-Oliveira
Diabetes in pregnancy, both preexisting type 1 or type 2 and gestational diabetes, is a highly prevalent condition, which has a great impact on maternal and fetal health, with short and long-term implications. Gestational Diabetes Mellitus (GDM) is a condition triggered by metabolic adaptation, which occurs during the second half of pregnancy. There is still a lot of controversy about GDM, from classification and diagnosis to treatment. Recently, there have been some advances in the field as well as recommendations from international societies, such as how to distinguish previous diabetes, even if first recognized during pregnancy, and newer diagnostic criteria, based on pregnancy outcomes, instead of maternal risk of future diabetes...
January 25, 2018: Journal of Clinical Medicine
https://www.readbyqxmd.com/read/29357718/the-cost-effectiveness-of-dulaglutide-versus-insulin-glargine-for-the-treatment-of-type-2-diabetes-mellitus-in-japan
#12
Hitoshi Ishii, Matthew Madin-Warburton, Alena Strizek, Lucy Thornton-Jones, Shuichi Suzuki
AIMS: Dulaglutide is a new once weekly glucagon-like peptide-1 (GLP-1) receptor agonist administered via a disposable auto-injection pen for the management of type 2 diabetes mellitus (T2DM). The objective of this study was to estimate the cost-effectiveness of dulaglutide versus insulin glargine for the management of T2DM from a Japanese healthcare perspective in accordance with recently approved Japanese Cost-Effectiveness Guidelines. METHODS: The IQVIA CORE Diabetes Model (version 9) was used to estimate the long-term costs and effects of treatment with dulaglutide and insulin glargine...
January 22, 2018: Journal of Medical Economics
https://www.readbyqxmd.com/read/29349708/cost-effectiveness-of-empagliflozin-for-the-treatment-of-patients-with-type-2-diabetes-mellitus-at-increased-cardiovascular-risk-in-greece
#13
George Gourzoulidis, Charalampos Tzanetakos, Ioannis Ioannidis, Apostolos Tsapas, Georgia Kourlaba, Giannis Papageorgiou, Nikos Maniadakis
BACKGROUND AND OBJECTIVE: Type 2 diabetes mellitus (T2DM) is frequently associated with co-morbidities that exacerbate cardiovascular (CV) risk. CV disease is the leading cause of death in people with diabetes across the world and accounts for approximately half the deaths in the T2DM population. Hence, the objective of present study was to evaluate the cost-effectiveness of empagliflozin, in addition to standard of care (SoC), for the treatment of adult patients with T2DM and high CV risk in Greece...
January 18, 2018: Clinical Drug Investigation
https://www.readbyqxmd.com/read/29316689/annual-direct-medical-costs-of-diabetic-foot-disease-in-brazil-a-cost-of-illness-study
#14
Cristiana M Toscano, Tatiana H Sugita, Michelle Q M Rosa, Hermelinda C Pedrosa, Roger Dos S Rosa, Luciana R Bahia
The aim of this study was to estimate the annual costs for the treatment of diabetic foot disease (DFD) in Brazil. We conducted a cost-of-illness study of DFD in 2014, while considering the Brazilian Public Healthcare System (SUS) perspective. Direct medical costs of outpatient management and inpatient care were considered. For outpatient costs, a panel of experts was convened from which utilization of healthcare services for the management of DFD was obtained. When considering the range of syndromes included in the DFD spectrum, we developed four well-defined hypothetical DFD cases: (1) peripheral neuropathy without ulcer, (2) non-infected foot ulcer, (3) infected foot ulcer, and (4) clinical management of amputated patients...
January 8, 2018: International Journal of Environmental Research and Public Health
https://www.readbyqxmd.com/read/29316141/the-association-of-hypoglycaemia-severity-and-clinical-patient-reported-and-economic-outcomes-in-us-patients-with-type-2-diabetes-using-basal-insulin
#15
Luigi F Meneghini, Lulu Lee, Shaloo Gupta, Ron Preblick
AIMS: To evaluate the clinical and patient-reported outcomes and healthcare utilization and costs associated with patient-reported hypoglycaemia in US adults with type 2 diabetes (T2D) treated with basal insulin. MATERIALS AND METHODS: This was an observational, cross-sectional, survey-based study of adults with T2D on basal insulin ± oral antidiabetes drugs (OADs) or rapid-acting/premix insulin who had in the past ever experienced hypoglycaemia, using US data from the National Health and Wellness Survey...
January 5, 2018: Diabetes, Obesity & Metabolism
https://www.readbyqxmd.com/read/29300755/incremental-cost-effectiveness-of-screening-and-laser-treatment-for-diabetic-retinopathy-and-macular-edema-in-malawi
#16
Damir Vetrini, Christine A Kiire, Philip I Burgess, Simon P Harding, Petros C Kayange, Khumbo Kalua, Gerald Msukwa, Nicholas A V Beare, Jason Madan
OBJECTIVE: To investigate the economic impact of introducing targeted screening and laser photocoagulation treatment for sight-threatening diabetic retinopathy and macular edema in a setting with no previous screening or laser treatment for diabetic retinopathy in sub-Saharan Africa. MATERIALS AND METHODS: A cohort Markov model was built to compare combined targeted screening and laser treatment for patients with sight-threatening diabetic retinopathy and macular edema against no intervention...
2018: PloS One
https://www.readbyqxmd.com/read/29298703/cultural-adaptation-of-a-peer-led-lifestyle-intervention-program-for-diabetes-prevention-in-india-the-kerala-diabetes-prevention-program-k-dpp
#17
Elezebeth Mathews, Emma Thomas, Pilvikki Absetz, Fabrizio D'Esposito, Zahra Aziz, Sajitha Balachandran, Meena Daivadanam, Kavumpurathu Raman Thankappan, Brian Oldenburg
BACKGROUND: Type 2 diabetes mellitus (T2DM) is now one of the leading causes of disease-related deaths globally. India has the world's second largest number of individuals living with diabetes. Lifestyle change has been proven to be an effective means by which to reduce risk of T2DM and a number of "real world" diabetes prevention trials have been undertaken in high income countries. However, systematic efforts to adapt such interventions for T2DM prevention in low- and middle-income countries have been very limited to date...
January 4, 2018: BMC Public Health
https://www.readbyqxmd.com/read/29277099/financial-incentives-for-medicaid-beneficiaries-with-diabetes-lessons-learned-from-hi-praise-an-observational-study-and-randomized-controlled-trial
#18
Ritabelle Fernandes, Chuan C Chinn, Dongmei Li, Timothy Halliday, Timothy B Frankland, Christina M B Wang, Zi Wang, Misha Morioka, Robin G Arndt, Rebecca Rude Ozaki
PURPOSE: The Hawaii Patient Reward and Incentives to Support Empowerment (HI-PRAISE) project examined the impact of financial incentives on Medicaid beneficiaries with diabetes. DESIGN: Observational pre-post study and randomized controlled trial (RCT). SETTING: Federally qualified health centers (FQHCs) and Hawaii Kaiser Permanente. PARTICIPANTS: The observational study included 2003 Medicaid beneficiaries with diabetes from FQHCs...
January 1, 2017: American Journal of Health Promotion: AJHP
https://www.readbyqxmd.com/read/29261739/relation-between-cost-of-drug-treatment-and-body-mass-index-in-people-with-type-2-diabetes-in-latin-america
#19
Jorge Federico Elgart, Mariana Prestes, Lorena Gonzalez, Enzo Rucci, Juan Jose Gagliardino
AIMS: Despite the frequent association of obesity with type 2 diabetes (T2D), the effect of the former on the cost of drug treatment of the latest has not been specifically addressed. We studied the association of overweight/obesity on the cost of drug treatment of hyperglycemia, hypertension and dyslipidemia in a population with T2D. METHODS: This observational study utilized data from the QUALIDIAB database on 3,099 T2D patients seen in Diabetes Centers in Argentina, Chile, Colombia, Peru, and Venezuela...
2017: PloS One
https://www.readbyqxmd.com/read/29261245/evaluation-of-the-quality-blue-primary-care-program-on-health-outcomes
#20
Qian Shi, Thomas J Yan, Peter Lee, Paul Murphree, Xiaojing Yuan, Hui Shao, William H Bestermann, Selina Loupe, Dawn Cantrell, David Carmouche, John Strapp, Lizheng Shi
OBJECTIVES: This study aimed to investigate the role of the Quality Blue Primary Care (QBPC) program on healthcare utilization and overall cost among the beneficiaries of Blue Cross and Blue Shield of Louisiana (BCBSLA). STUDY DESIGN: Retrospective observational cohort study using claims data from adults residing in QBPC-implemented regions continuously enrolled through BCBSLA from June 2012 to December 2014 (N = 89,034). METHODS: Controlling for age, gender, and risk score by propensity score weighting, inpatient, outpatient, and corresponding medical expenditures were each compared between the QBPC group and the control group using a difference-in-differences regression model...
December 1, 2017: American Journal of Managed Care
keyword
keyword
41494
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"